• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无标记基因编辑在... 中的应用。

Markerless gene editing in .

机构信息

Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.

出版信息

Microbiology (Reading). 2022 Jun;168(6). doi: 10.1099/mic.0.001201.

DOI:10.1099/mic.0.001201
PMID:35763318
Abstract

, the gonococcus, is a pathogen of major public health concern, but sophisticated approaches to gene manipulation are limited for this species. For example, there are few methods for generating markerless mutations, which allow the generation of precise point mutations and deletions without introducing additional DNA sequence. Markerless mutations are central to studying pathogenesis, the spread of antimicrobial resistance (AMR) and for vaccine development. Here we describe the use of as a counter-selectable marker that can be used for markerless mutagenesis in . encodes galactokinase, an enzyme that metabolizes galactose in bacteria that can utilize it as a sole carbon source. GalK can also phosphorylate a galactose analogue, 2-deoxy-galactose (2-DOG), into a toxic, non-metabolisable intermediate, 2-deoxy-galactose-1-phosphate. We utilized this property of GalK to develop a markerless approach for mutagenesis in . We successfully deleted both chromosomally and plasmid-encoded genes, that are important for gonococcal vaccine development and studies of AMR spread. We designed a positive-negative selection cassette, based on an antibiotic resistance marker and , that efficiently rendered susceptible to growth on 2-DOG. We then adapted the -based counter-selection and the use of 2-DOG for markerless mutagenesis, and applied biochemical and phenotypic analyses to confirm the absence of target genes. We show that our markerless mutagenesis method for has a high success rate, and should be a valuable gene editing tool in the future.

摘要

淋病奈瑟菌是一种主要的公共卫生关注病原体,但该物种的基因操作方法还不够复杂。例如,几乎没有产生无标记突变的方法,而无标记突变可以在不引入额外 DNA 序列的情况下产生精确的点突变和缺失。无标记突变是研究发病机制、抗微生物药物耐药性(AMR)传播以及疫苗开发的核心。在这里,我们描述了使用 作为一种可选择的标记,可用于淋病奈瑟菌的无标记诱变。 编码半乳糖激酶,这是一种可以代谢能将其作为唯一碳源的细菌中的半乳糖的酶。GalK 还可以将半乳糖类似物 2-脱氧半乳糖(2-DOG)磷酸化为有毒的、不可代谢的中间产物 2-脱氧半乳糖-1-磷酸。我们利用 GalK 的这一特性,开发了一种用于淋病奈瑟菌无标记诱变的方法。我们成功地删除了对淋球菌疫苗开发和 AMR 传播研究都很重要的染色体和质粒编码基因。我们设计了一个基于抗生素抗性标记和 的正负选择盒,有效地使 对 2-DOG 的生长敏感。然后,我们适应了基于的反向选择和 2-DOG 的无标记诱变,并用生化和表型分析来确认靶基因的缺失。我们表明,我们用于 的无标记诱变方法成功率很高,将来应该成为一种有价值的基因编辑工具。

相似文献

1
Markerless gene editing in .无标记基因编辑在... 中的应用。
Microbiology (Reading). 2022 Jun;168(6). doi: 10.1099/mic.0.001201.
2
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes.2008年世界卫生组织淋病奈瑟菌参考菌株组的表型和基因特征,旨在用于公共卫生目的的淋球菌抗菌药物耐药性监测的全球质量保证和质量控制。
J Antimicrob Chemother. 2009 Jun;63(6):1142-51. doi: 10.1093/jac/dkp098. Epub 2009 Mar 24.
3
Direct selection of galactokinase-negative mutants of Candida albicans using 2-deoxy-galactose.使用2-脱氧半乳糖直接筛选白色念珠菌的半乳糖激酶阴性突变体。
Curr Genet. 1992 Mar;21(3):203-6. doi: 10.1007/BF00336842.
4
Repurposed Drugs That Block the Gonococcus-Complement Receptor 3 Interaction Can Prevent and Cure Gonococcal Infection of Primary Human Cervical Epithelial Cells.可阻断淋球菌-补体受体 3 相互作用的再利用药物可预防和治疗淋球菌对原代人宫颈上皮细胞的感染。
mBio. 2020 Mar 3;11(2):e03046-19. doi: 10.1128/mBio.03046-19.
5
Construction of mutant strains of Neisseria gonorrhoeae lacking new antibiotic resistance markers using a two gene cassette with positive and negative selection.利用具有正选择和负选择的双基因盒构建缺乏新抗生素抗性标记的淋病奈瑟菌突变株。
Gene. 1999 Aug 5;236(1):179-84. doi: 10.1016/s0378-1119(99)00238-3.
6
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.2011 - 2012年南京性传播疾病门诊有症状男性淋病奈瑟菌分离株的抗菌药物敏感性:对头孢曲松敏感性降低的分离株的遗传特征
BMC Infect Dis. 2014 Nov 27;14:622. doi: 10.1186/s12879-014-0622-0.
7
Antibiotic susceptibility patterns and plasmid profiles of penicillinase-producing Neisseria gonorrhoeae strains in Durban, South Africa, 1990-1993.1990 - 1993年南非德班产青霉素酶淋病奈瑟菌菌株的抗生素敏感性模式及质粒图谱
Sex Transm Dis. 1997 Jan;24(1):18-22. doi: 10.1097/00007435-199701000-00005.
8
Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women.自然感染淋病奈瑟菌转录组分析显示男女之间抗生素耐药决定因素的差异表达。
mSphere. 2018 Jun 27;3(3). doi: 10.1128/mSphereDirect.00312-18. Print 2018 Aug 29.
9
Galactose utilization in Lactobacillus helveticus: isolation and characterization of the galactokinase (galK) and galactose-1-phosphate uridyl transferase (galT) genes.瑞士乳杆菌中半乳糖的利用:半乳糖激酶(galK)和1-磷酸半乳糖尿苷酰转移酶(galT)基因的分离与鉴定
J Bacteriol. 1991 Jul;173(14):4464-73. doi: 10.1128/jb.173.14.4464-4473.1991.
10
A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae.淋病奈瑟菌中单个碱基对改变导致高水平、广谱抗生素耐药的新机制。
mBio. 2011 Sep 20;2(5). doi: 10.1128/mBio.00187-11. Print 2011.

引用本文的文献

1
Origin, evolution, and success of pbla, the gonococcal beta-lactamase plasmid, and implications for public health.淋球菌β-内酰胺酶质粒pbla的起源、进化与成功及其对公共卫生的影响
PLoS Pathog. 2025 May 6;21(5):e1013151. doi: 10.1371/journal.ppat.1013151. eCollection 2025 May.
2
Expanding the genetic toolbox for with efficient tools for unmarked gene editing, complementation, and labeling.利用高效的无标记基因编辑、互补和标记工具,扩展 的遗传工具包。
Appl Environ Microbiol. 2024 Sep 18;90(9):e0088024. doi: 10.1128/aem.00880-24. Epub 2024 Aug 14.
3
Evolution and exchange of plasmids in pathogenic .
在病原. 中质粒的进化和交换。
mSphere. 2023 Dec 20;8(6):e0044123. doi: 10.1128/msphere.00441-23. Epub 2023 Oct 18.
4
Development of a counterselectable system for rapid and efficient CRISPR-based genome engineering in Zymomonas mobilis.开发一种反选择系统,用于快速高效的基于 CRISPR 的酿酒酵母基因组工程。
Microb Cell Fact. 2023 Oct 13;22(1):208. doi: 10.1186/s12934-023-02217-9.
5
Multisite transformation in : insights on transformations mechanisms and new genetic modification protocols.多部位转化:转化机制及新基因修饰方案的见解
Front Microbiol. 2023 Jun 20;14:1178128. doi: 10.3389/fmicb.2023.1178128. eCollection 2023.
6
Evolution, persistence, and host adaption of a gonococcal AMR plasmid that emerged in the pre-antibiotic era.在抗生素出现之前就已经出现的淋球菌 AMR 质粒的进化、持续存在和宿主适应。
PLoS Genet. 2023 May 15;19(5):e1010743. doi: 10.1371/journal.pgen.1010743. eCollection 2023 May.